Assessment of estrogenic potential of di-n-butyl phthalate and butyl benzyl phthalate in vivo

Toxicology and Industrial Health

Volumn 31, Issue 12, 2015, Pages 1296-1303

  Ahmad, Rahish ^a   Verma, Yogendra ^a   Gautam, Anil K ^a   Kumar, Sunil ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (India)

Author keywords

butyl benzyl phthalate; Dibutyl phthalate; diethylstilbestrol; estrous cyclicity; female pubertal assay; uterotrophic assay; vaginal opening

Indexed keywords

DIETHYLSTILBESTROL; PHTHALIC ACID BENZYL BUTYL ESTER; PHTHALIC ACID DIBUTYL ESTER; ESTROGEN; PHTHALIC ACID DERIVATIVE; PLASTICIZER; POLLUTANT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESTROGEN ACTIVITY; ESTRUS CYCLE; FEMALE; IN VIVO STUDY; NONHUMAN; OVARY; PREPUBERTY; PUBERTY; RAT; UTERUS WEIGHT; VAGINA; ANIMAL; CHEMICALLY INDUCED; COMPARATIVE STUDY; DISORDER OF SEX DEVELOPMENT; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ORAL DRUG ADMINISTRATION; ORGAN SIZE; PATHOLOGY; POLLUTANT; REPRODUCIBILITY; SEXUAL MATURATION; TOXICITY; TOXICITY TESTING; UTERUS;

ADMINISTRATION, ORAL; ANIMALS; DIBUTYL PHTHALATE; DISORDERS OF SEX DEVELOPMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL POLLUTANTS; ESTROGENS, NON-STEROIDAL; ESTROUS CYCLE; FEMALE; ORGAN SIZE; OVARY; PHTHALIC ACIDS; PLASTICIZERS; RATS; REPRODUCIBILITY OF RESULTS; SEXUAL MATURATION; TOXICITY TESTS; UTERUS; VAGINA;

EID: 84948661249     PISSN: 07482337     EISSN: 14770393     Source Type: Journal    
DOI: 10.1177/0748233713491803     Document Type: Article

References (34)

1. Brady AM, Moffat GJ, Hall MG, Martens F, Martens M, Nair R (1998) An assessment if in vivo estrogenic activity of butylbenzyl phthalate and its principal metabolites. Toxicologist 42: 176–177.
2. Branham WS, Zehr DR, Chen JJ, Sheehan DM (1998) Uterine abnormalities in rats exposed neonatally to diethylstilbestrol, ethynylestradiol, or clomiphene citrate. Toxicology 51: 201–212.
3. Branham WS, Zehr DR, Sheehan DM (1993) Differential sensitivity of rat uterine growth and epithelium hypertrophy to estrogens and antiestrogens. Proceedings of the Society for Experimental Biology and Medicine 203: 297–303.
4. Clark JH, Watson C, Upchurch S, McCormack S, Padykula H, Markaverich B et al. (1980) Estrogen action in normal and abnormal cell growth. In: McLachlan JA (ed) Estrogens in the Environment. New York, NY: Elsevier, pp. 53–67.
5. Coldham NG, Dave M, Sivapthasundaram S, McDonnell DP, Connor C, Sauer M (1997) Evaluation of a recombinant yeast cell estrogen-screening assay. Environmental Health Perspectives 105: 734–742.
6. De George GL, Mitchell JM, Newcomb T, Newcomb G, Kieffer L, Cerven DR (1997) Development of a uterotrophic response assay for assessment of estrogenic activity and reproductive system toxicity of dermally applied industrial chemicals and environmental pollutants. Fundamental and Applied Toxicology (Suppl. Toxicol.) 36: 59.
7. Eigenberg DA, Bozigian HP, Carter DE, Sipes IG (1986) Distribution, excretion and metabolism of butylbenzyl phthalate in the rat. Toxicology and Environmental Health 17: 445–456.
8. Everett JW (1989) Neurobiology of Reproduction in Female Rat: A Fifty-Year Perspective. New York, NY: Springer-Verlag.
9. Harris CA, Henttta P, Parker MG, Sumpter JP (1997) The estrogenic activity of phthalate esters in vitro. Environmental Health Perspectives 105: 802–811.
10. Kanno J, Onyon L, Haseman J, Fenner-Crisp P, Ashby J, Owens W (2001) The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1. Environmental Health Perspectives 109: 785–794.
11. Kanno J, Onyon L, Peddada S, Ashby J, Jacob E, Owens W (2003) The OECD program to validate the rat uterotrophic bioassay. Phase2: coded single dose studies. Environmental Health Perspectives 111: 1550–1558.
12. Kim HS, Shin JH, Moon HJ, Kim TS, Kang IH, Seok JH et al. (2002) Evaluation of the 20-day pubertal female assay in Sprague-Dawley rats treated with DES, tamoxifen, testosterone, and flutamide. Toxicological Sciences 67: 52–62.
13. Korach KS, McLachlan JA (1995) Techniques for detection of estrogenicity. Environmental Health Perspectives 103: 5–8.
14. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL (2000) Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicological Sciences 54: 154–167.
15. Lindzey J, Korach KS (1997) Development and physiological effects of estrogen receptor gene disruption in mice. Trends in Endocrinology and Metabolism 8: 137–145.
16. Marty MS, Crissman JW, Carney EW (1999) Evaluation of the EDSTAC female pubertal assay in CD rats using 17- beta-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicological Sciences 52: 269–277.
17. McLachlan JA (1993) Functional toxicology: a new approach to detect functionally active xenobiotics. Environmental Health Perspectives 101: 386–387.
18. McLachlan JA, Korach KS (1995) Symposium on estrogens in the environment, III. Environmental Health Perspectives 103: 3–4.
19. Milligan SR, Balasubramanian AV, Kalita JC (1998) Relative potency of xeniobiotics estrogen in an acute in vivo mammalian assay. Environmental Health Perspectives 106: 23–26.
20. Monsanto (1996) Study to evaluate the effect of butyl benzyl phthalate on uterin growth in immature female rats after subcutaneous administration. Project No. Xx96.245 CTL/R/1278. Cheshire, UK: Central Toxicology Laboratory.
21. Moore NP (2000) The Oestrogenic potential of the phthalate esters. Reproductive Toxicology 14: 183–192.
22. O’Connor JC, Cook JC, Craven SC, Pelt CSV, Obourn JD (1996) An in vivo battery for identifying endocrine modulators that are estrogenic or dopamine regulators. Fundamental and Applied Toxicology 33: 182–195.
23. O’Connor JC, Davis LG, Frame SR, Cook JC (2000) Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicological Sciences 54: 338–354.
24. Odum J, Lefevre PA, Tittensor S, Paton D, Routledge EJ, Beresford NA et al. (1997) The Rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regulatory Toxicology and Pharmacology 25: 176–188.
25. OECD (1999) Guidance and Protocol for the Prevalidation of the Rat Uterotrophic Screening Assay. Paris, France: Organization for Economic Co-operation and Development, ENV/JM/TG/EDTA: 99 2/ANN 1.
26. Ramaley JA (1981) Serum prolactin levels in the prepubertal period in male and female rats. Control by photoperiod and gonadal status and relationship to puberty onset. International Journal of Andrology 4: 91–104.
27. Ramirez VD, Sawyer CH (1965) Advancement of puberty in the female rat by estrogen. Endocrinology 76: 1158–1168.
28. Sharpe RM, Fisher JS, Millar MM, Jobling S, Sumpter JP (1995) Gestational and lactational exposure of rats to xenoestrogens results in reduced testicular size and sperm production. Environmental Health Perspectives 103: 1136–1143.
29. Takahashi T, Tanaka A (1989) Biochemical studies on phthalic esters. Comparative studies on in vitro hydrolysis of di- n-butyl phthalate isomers in rats. Archives of Toxicology 63: 72–74.
30. US EPA Integrated Risk Information system (IRIS) (1990) Dibutyl phthalate. Available at: www.epa.gov/iris/subst/0038.htm (accessed 15 December 2012).
31. US EPA Integrated Risk Information system (IRIS) (1993) Butyl benzyl phthalate. Available at: www.epa.gov/iris/subst/0293.htm (accessed 15 December 2012).
32. Wang Y, DeMayo FJ, Tsai SY, O’Malley BW (1997) Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology 15: 239–243.
33. Wine R, Li LH, Barnes LH, Gulati DK, Chapin RE (1997) Reproductive toxicity of di- n-butylphthalate in a continuous breeding protocol in Sprague-Dawley rats. Environmental Health Perspectives 105: 102–107.
34. Zacharewski TR, Meek MD, Clemons JH, Wu ZF, Fielden MR, Matthews JB (1998) Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters. Toxicological Science 46: 282–293.